Medical and Pharmaceutical Portage Biotech soars after initiating proceedings for iOx Therapeutics sale The stock went up by over 185% after the LOI was announced Rowan DunneDecember 17, 2024
Business Pfizer buys firm with cannabinoid therapy in clinical trial Olorinab is a CB2 receptor agonist in a Phase 2 trial for IBS Nick LabaDecember 15, 2021